Wanyuan Cui

769 total citations
30 papers, 290 citations indexed

About

Wanyuan Cui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wanyuan Cui has authored 30 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wanyuan Cui's work include Lung Cancer Treatments and Mutations (11 papers), Reproductive Biology and Fertility (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Wanyuan Cui is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Reproductive Biology and Fertility (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Wanyuan Cui collaborates with scholars based in United Kingdom, Australia and United States. Wanyuan Cui's co-authors include Sanjay Popat, Gregory Armstrong, Viengnakhone Vongxay, Richard A. Anderson, Mayfong Mayxay, Vanphanom Sychareun, Kelly‐Anne Phillips, Roseanne Rosario, Maarten J. IJzerman and Marliese Alexander and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

Wanyuan Cui

26 papers receiving 285 citations

Peers

Countries citing papers authored by Wanyuan Cui

Since Specialization

Citations

This map shows the geographic impact of Wanyuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanyuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanyuan Cui more than expected).

Fields of papers citing papers by Wanyuan Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanyuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanyuan Cui. The network helps show where Wanyuan Cui may publish in the future.

Co-authorship network of co-authors of Wanyuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Wanyuan Cui. A scholar is included among the top collaborators of Wanyuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanyuan Cui. Wanyuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Mitochondrial DNA‐Releasing Photosensitizer Potentiates Innate Immunity for Tumor Eradication and Prevention 2025 ·Aggregate ·Yingli An, Min Li, (unknown), Wanyuan Cui, Hou‐Yong Yu, Peng Wang, Pinning Feng, Duo Mao	0
2	Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials 2022 ·The Breast ·Wanyuan Cui, Kelly‐Anne Phillips, Prudence A. Francis, Richard A. Anderson, Ann H. Partridge, Sherene Loi, Sibylle Loibl, Louise Keogh	4
3	Crizotinib-Resistant ROS1 G2101A Mutation Associated With Sensitivity to Lorlatinib in ROS1-Rearranged NSCLC: Case Report 2022 ·JTO Clinical and Research Reports ·(unknown), Wanyuan Cui, Sanjay Popat	4
4	A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer 2022 ·Lung Cancer ·Wanyuan Cui, (unknown), Terri McVeigh, Anna Minchom, (unknown), Michael Davidson, Nadia Yousaf, (unknown), Hood Mugalaasi, R. Gunapala, Richard Lee, Angela George, Sanjay Popat, Mary O’Brien	21
5	Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders. 2022 ·PubMed ·Wanyuan Cui, Kelly‐Anne Phillips, Richard A. Anderson, Prudence A. Francis, Sherene Loi, Sibylle Loibl, Ann H. Partridge, Louise Keogh	0
6	Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience 2022 ·Lung Cancer ·Wanyuan Cui, Nick Brown, Victoria Brown, (unknown), Arshi Denton, (unknown), M. Förster, Dionysis Papadatos-Pastos, Loredana Pellegrino, (unknown), Rolf Bruns, Gordon Otto, Paul K. Paik	2
7	Up Front Cell Free DNA Next Generation Sequencing Improves Target Identification in UK First Line Advanced Non-Small Cell Lung Cancer (NSCLC) Patients 2022 ·SSRN Electronic Journal ·Wanyuan Cui, (unknown), (unknown), (unknown), Anna Minchom, Jaishree Bhosle, Michael Davidson, Nadia Yousaf, (unknown), Iris Faull, (unknown), Rebecca J. Nagy, Mary O’Brien, Sanjay Popat	3
8	Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation 2021 ·JNCI Journal of the National Cancer Institute ·Wanyuan Cui, Prudence A. Francis, Sherene Loi, Martha Hickey, Catharyn Stern, Lumine Na, Ann H. Partridge, Sibylle Loibl, Richard A. Anderson, Karla J. Hutt, Louise Keogh, Kelly‐Anne Phillips	17
9	Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma 2021 ·Drugs ·Wanyuan Cui, Sanjay Popat	3
10	Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications 2021 ·Frontiers in Medicine ·Sumeet Hindocha, (unknown), Merina Ahmed, (unknown), Bhupinder Sharma, Nadia Yousaf, Philip L. Molyneaux, Benjamin Hunter, (unknown), Wanyuan Cui, Michael Davidson, Jaishree Bhosle, Anna Minchom, Imogen Locke, Fiona McDonald, Mary O’Brien, Sanjay Popat, Richard Lee	5
11	180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19 2021 ·Journal of Thoracic Oncology ·Wanyuan Cui, (unknown), (unknown), Jaishree Bhosle, Anna Minchom, Michael Davidson, (unknown), Imogen Locke, Nadia Yousaf, Sanjay Popat, Mary O’Brien	3
12	Exploring the facilitators and barriers to using an online infertility risk prediction tool (FoRECAsT) for young women with breast cancer: a qualitative study protocol 2020 ·BMJ Open ·(unknown), Yasmin Jayasinghe, Martha Hickey, Lesley Stafford, Richard A. Anderson, H. Irene Su, (unknown), Christobel Saunders, Antoinette Anazodo, (unknown), Shanton Chang, Patrick Cheong‐Iao Pang, Franca Agresta, (unknown), Wanyuan Cui, (unknown), (unknown), Michelle Peate	0
13	1352P Circulating tumour (ct) DNA next generation sequencing (NGS) in advanced non-small cell lung cancer (mNSCLC): A UK single institution experience 2020 ·Annals of Oncology ·Wanyuan Cui, (unknown), Iris Faull, Rebecca J. Nagy, (unknown), Anna Minchom, Jaishree Bhosle, Nadia Yousaf, Mary O’Brien, Sanjay Popat	1
14	Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience 2020 ·Cancer Treatment and Research Communications ·Wanyuan Cui, Nadia Yousaf, Jaishree Bhosle, Anna Minchom, Andrew G. Nicholson, Merina Ahmed, Fiona McDonald, Imogen Locke, Richard Lee, Mary O’Brien, Sanjay Popat	3
15	Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer 2020 ·Lung Cancer ·Wanyuan Cui, Fanny Franchini, Marliese Alexander, (unknown), Hui‐Li Wong, Maarten J. IJzerman, Jayesh Desai, Benjamin Solomon	41
16	Assessing real-world outcomes in metastatic colorectal cancer with KRAS^G12C mutation. 2020 ·Journal of Clinical Oncology ·Hui‐Li Wong, Wanyuan Cui, (unknown), Margaret Lee, Rachel Wong, Jeremy Shapiro, Jeanne Tie, Belinda Lee, Prasad Cooray, (unknown), Peter Gibbs, Benjamin Solomon, Jayesh Desai	1
17	Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort. 2020 ·Journal of Clinical Oncology ·Wanyuan Cui, Fanny Franchini, Marliese Alexander, (unknown), Hui‐Li Wong, Maarten J. IJzerman, Jayesh Desai, Benjamin Solomon	3
18	Dose modification for haematological toxicity: a survey of Australian medical oncologists 2019 ·Internal Medicine Journal ·Wanyuan Cui, (unknown), (unknown), Aisling Kelly, (unknown), (unknown), Craig Lewis, B. Stein, Jeremy Shapiro, Christos S. Karapetis, Rachel Wong	1
19	Conservative management of reproductive cancers. Ovarian protection during treatment 2018 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·Wanyuan Cui, Kelly‐Anne Phillips	4
20	Dengue in peri-urban Pak-Ngum district, Vientiane capital of Laos: a community survey on knowledge, attitudes and practices 2013 ·BMC Public Health ·Mayfong Mayxay, Wanyuan Cui, (unknown), (unknown), Viengnakhone Vongxay, (unknown), Vanphanom Sychareun, Gregory Armstrong	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact